Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA–induced dyskinesia
INTRODUCTIONSince its introduction for the treatment of Parkinson’s disease (PD), l-3,4-dihydroxyphenylalanine (l-DOPA) remains the most effective therapy for alleviating parkinsonian...











